Psychedelic drugs should be legally reclassified so that researchers can investigate their therapeutic potential
BMJ May 26, 2015 DOI: 10.1136/bmj.h2902 (opens in new tab) via OpenAlex
Summary
AI-generated from the abstractJames J H Rucker argues that conducting trials of physiologically safe and non-addictive drugs like LSD is nearly impossible under current regulations, and calls on authorities to downgrade their unnecessarily restrictive Class A, Schedule 1 classification.
Study at a glance
| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Topics | Addiction |
| Keywords | Downgrade Class philosophy Psychology Drug class |
| Citations | 27 |
| Key finding | Argues that the restrictive classification of LSD as Class A, Schedule 1 makes clinical trials nearly impossible and calls for its downgrade. |
Abstract
Trials of physiologically safe and non-addictive drugs such as LSD are almost impossible, writes James J H Rucker, calling on the authorities to downgrade their unnecessarily restrictive class A, schedule 1 classification